NCT04338776.

Study name	Comparing UroLift experience against Rezūm (CLEAR)
Methods	Study design: parallel randomized controlled trial (open label) Setting/Country: not reported
Participants	Inclusion criteria Male gender Age ≥ 50 years Diagnosis of symptomatic BPH Prostate volume 30 mL to 80 mL Willing to sign study informed consent form
Interventions	Group A: UroLift (prostatic urethral lift) Group B: Rezūm (convective radiofrequency water vapor thermal therapy)
Outcomes	Primary outcome Catheter Independent (number of subjects who are catheter independent post‐operative day 4 and remain catheter independent through 1‐week)
Starting date	August 2020
Contact information	emily.friedland@teleflex.com
Notes	Sponsor: NeoTract, Inc.

BPH: benign prostatic hyperplasia; IIEF: International Index of Erectile Function; IPSS: International Prostate Symptom Score; LUTS: lower urinary tract symptoms; MRI: magnetic resonance imaging; PAE: prostatic arterial embolization; PSA: prostate specific antigen; PVR: post void residual; Q_max: maximum flow rate; QoL: quality of life; TURP: transurethral resection of prostate.